Skip to Content
Rush-Copley Medical Group
Home > Health & Fitness > Healthwise > COPD and Alpha-1 Antitrypsin (AAT) Deficiency
Alpha-1 antitrypsin (AAT) is a protein normally found in
the lungs and the bloodstream. It helps protect the lungs from the damage
caused by inflammation that can lead to
chronic obstructive pulmonary disease (COPD). People
whose bodies do not produce enough of this protein (AAT deficiency) are more
likely to develop emphysema and to do so at a younger-than-normal age (30 to 40
years old). AAT deficiency is a rare disorder and is the only known
genetic (inherited) factor that increases your risk of
Your doctor may suspect you have an AAT
deficiency if you:1
An AAT deficiency test measures the level of AAT in the
blood. The test is not routinely done in most people with COPD. But the
American Thoracic Society and the European Respiratory Society recommend
testing for an AAT deficiency for people who have:1
Screening for an AAT deficiency in the general public is not
It is extremely important that you do not
smoke if you have an AAT deficiency. Smokers with this condition may suffer
devastating disease at a young age. People with this condition who have never
smoked usually do not have significant symptoms at any age.
Treatment for COPD may include medicines to help you breathe easier. It may also include pulmonary rehabilitation. This means learning exercise, eating, and breathing tips and other ways to help yourself stay as healthy and strong as you can. And your doctor may suggest that you have injections of man-made
alpha-1 antitrypsin protein (also called an alpha-1 proteinase inhibitor) that
has been obtained from human
plasma. Examples include Aralast, Prolastin, and
Zemaira. To be considered for this treatment, you must meet the following
Injections of replacement alpha-1 antitrypsin are given
either weekly or every 2 to 4 weeks. Benefits of the therapy are not clear at
American Thoracic Society/European Respiratory Society
(2003). ATS/ERS: Standards for the diagnosis and management of individuals with
alpha1-antitrypsin deficiency. American Journal of Respiratory and Critical Care Medicine, 168(7): 820–822.
Current as of:
January 24, 2014
E. Gregory Thompson, MD - Internal Medicine & Ken Y. Yoneda, MD - Pulmonology
How this information was developed to help you make better health decisions.
To learn more, visit Healthwise.org
© 1995-2014 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Retrieving newsletters from the Web service...
Sorry, the newsletter Web service is unavailable at this time.
You have signed up for the selected newsletters.
© Copyright 2015 Rush-Copley Medical Center • 2000 Ogden Avenue; Aurora, IL 60504
Main: 630-978-6200 • Physician Referral & Information: 630-978-6700 or 866-4COPLEY (866-426-7539)